Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Burning Rock Biotech Ltd BNR

Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation... see more

Recent & Breaking News (NDAQ:BNR)

Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 28, 2024

Burning Rock Announces Receipt of Notification from NASDAQ

GlobeNewswire January 4, 2024

Burning Rock Announces Results of 2023 Annual General Meeting

GlobeNewswire December 19, 2023

Burning Rock Reports Third Quarter 2023 Financial Results

GlobeNewswire November 30, 2023

Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023

GlobeNewswire November 22, 2023

Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023

GlobeNewswire November 20, 2023

Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics

GlobeNewswire October 30, 2023

Burning Rock Received Breakthrough Device Designation from China's NMPA for its Multi-Cancer Early Detection Test

GlobeNewswire October 15, 2023

Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell

GlobeNewswire September 7, 2023

Burning Rock Reports Second Quarter 2023 Financial Results

GlobeNewswire August 31, 2023

Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023

GlobeNewswire August 4, 2023

Burning Rock Announces Resignation and Appointment of Directors

GlobeNewswire June 28, 2023

Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine

GlobeNewswire June 8, 2023

Burning Rock Reports First Quarter 2023 Financial Results

GlobeNewswire May 30, 2023

Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023

GlobeNewswire April 27, 2023

Burning Rock Publishes 2022 Annual Report on Form 20-F

GlobeNewswire April 20, 2023

Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 28, 2023

Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023

GlobeNewswire March 7, 2023

Burning Rock provides an update on 2022 revenue guidance

GlobeNewswire January 17, 2023

Burning Rock Received FDA Breakthrough Device Designation for its OverC(TM) Multi-Cancer Detection Blood Test

PR Newswire January 3, 2023